Clinical trial Recruiting at 1 site Interventional Ages 21 to 65

Modified TLIP vs Retrolaminar block for pain after two-level lumbar spine surgery

Official title: Effect of Modified Thoracolumbar Interfascial Plane Block Versus Retrolaminar Block for Pain Control in Postoperative Lumbar Spine Surgeries: A Prospective Randomized Double-Blind Clinical Study

Run by Zagazig University · NCT07883616 · Data updated 2026-11-12

This randomized trial tests whether the modified TLIP block provides better early pain control and less opioid use than the retrolaminar block after two-level lumbar spine surgery, in adults aged 21–65.

Quick facts

Study typeInterventional
Ages21 Years to 65 Years
SexAll
Enrollment42 (estimated)
SponsorZagazig University
Government
Locations1 site (Zagazig, Sharqia Province)
StatusRecruiting
StartedOctober 1, 2025
Main results expectedDecember 1, 2026
Study endsJanuary 1, 2027
Registry record updatedOctober 20, 2026
Trial IDNCT07883616 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 21–65 with ASA I–II undergoing elective two-level lumbar spine surgery (discectomy/decompression) and who consent to participate.

Probably not a fit

Patients whose pain control relies more on systemic analgesia or who have contraindications to regional blocks may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, randomized, double-blind study compares two regional anesthesia techniques—modified Thoracolumbar Interfascial Plane (mTLIP) block and Retrolaminar block—for managing postoperative pain in adults undergoing elective two-level lumbar spine procedures. The primary outcome is total morphine consumption in the first 24 hours after surgery. Secondary outcomes include pain scores, time to first rescue analgesia, block performance metrics, side effects, functional recovery, and patient satisfaction. Local anesthetic is administered with adjuncts and the approach targets dorsal rami to reduce opioid needs while facilitating recovery. The trial will help determine which block offers more effective analgesia with potentially fewer opioid-related adverse effects.

Why it matters

Potential benefit: If successful, the preferred block could reduce opioid requirements and improve early postoperative comfort after lumbar spine surgery.

How similar studies have gone: Regional block comparisons for lumbar surgery have shown potential for opioid-sparing effects, though direct head-to-head data on mTLIP versus retrolaminar is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 21 and 65 years
* ASA physical status I or II
* BMI \< 30 kg/m²
* Scheduled for elective two-level lumbar spine surgery (discectomy/decompression)
* Expected duration of surgery less than 3 hours
* Patient's acceptance and written informed consent

Exclusion Criteria:

* Infection at block site
* Known allergy to used drugs
* Coagulation disorder
* History of psychiatric illness
* Pre-existing neurological deficits
* Presence of any metastasis
* Previous lumbar spine surgeries
* Patients on previous opioid therapy

Where it's running

  • Zagazig University Hospitals, Anesthesia, Intensive Care and Pain Management Department
    Zagazig, Sharqia Province, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.